Tuberculosis control in South Africa: Successes, challenges and recommendations

South African Medical Journal

Volumn 104, Issue 3, 2014, Pages 244-248

  Churchyard, G J ^a,b,c   Mametja, L D ^d   Mvusi, L ^d   Ndjeka, N ^d   Hesseling, A C ^e   Reid, A ^f   Babatunde, S ^g   Pillay, Y ^d  

^a AURUM INSTITUTE   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d NATIONAL DEPARTMENT OF HEALTH   (South Africa)

^e STELLENBOSCH UNIVERSITY   (South Africa)

^f UNAIDS ^*  (South Africa)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

HIV; Millenium development goals; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; CHILDHOOD DISEASE; DISEASE SURVEILLANCE; GOVERNMENT; HEALTH CARE FACILITY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; PRACTICE GUIDELINE; SCREENING TEST; SEROPREVALENCE; SOUTH AFRICA; SPUTUM SMEAR; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; HUMANS; NATIONAL HEALTH PROGRAMS; PREVALENCE; SOUTH AFRICA; TUBERCULOSIS;

EID: 84894764851     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.7689     Document Type: Article

References (32)

1. World Health Organization. Global Tuberculosis Report 2012. http://www.who.int/tb/publications/global_report/gtbr12_main.pdf (accessed 21 January 2014).
2. Abdool Karim SS, Churchyard GJ, Karim QA, Lawn SD. HIV infection and tuberculosis in South Africa: An urgent need to escalate the public health response. Lancet 2009;374(9693):921-933. [http://dx.doi.org/10.1016/S0140-6736(09)60916-8]
3. National Department of Health. National Strategic Plan on HIV, STIs and TB: 2012-2016. http://www doh.gov.za/docs/stratdocs/2012/NSPfull.pdf (accessed 14 October 2013).
4. Scott LE, Gous N, Cunningham BE, et al. Dried culture spots for Xpert MTB/RIF external quality assessment: Results of a phase 1 pilot study in South Africa. J Clin Microbiol 2011;49(12):4356-4360. [http://dx.doi.org/10.1128/JCM.05167-11]
5. Claassens MM, du Toit E, Dunbar R, et al. Tuberculosis patients in primary care do not start treatment: What role do health system delays play? Int J Tuberc Lung Dis 2013;17(5):603-607. [http://dx.doi.org/10.5588/ijtld.12.0505]
6. Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2009;362(8):697-706. [http://dx.doi.org/10.1056/NEJMoa0905848]
7. Kufa T, Mngomezulu V, Charalambous S, et al. Undiagnosed tuberculosis among HIV clinic attendees: Association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control. J Acquir Immune Defic Syndr 2012;60(2):e22-e28. [http://dx.doi.org/10.1097/QAI.0b013e318251ae0b]
8. Rangaka MX, Wilkinson RJ, Glynn JR, et al. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis 2012;55(12):1698-1706. [http://dx.doi.org/10.1093/cid/cis775]
9. Van Wyk SS, Mandalakas AM, Enarson DA, Gie RP, Beyers N, Hesseling AC. Tuberculosis contact investigation in a high-burden setting: House or household? Int J Tuberc Lung Dis 2012;16(2):157-162. [http://dx.doi.org/10.5588/ijtld.11.0393]
10. Mandalakas AM, Hesseling AC, Gie RP, Schaaf HS, Marais BJ, Sinanovic E. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax 2013;68(3):247-255. [http://dx.doi.org/10.1136/thoraxjnl-2011-200933]
11. Bekker A, du Preez K, Schaaf HS, Cotton MF, Hesseling AC. High tuberculosis exposure among neonates in a high tuberculosis and human immunodeficiency virus burden setting. Int J Tuberc Lung Dis 2012;16(8):1040-1046. [http://dx.doi.org/10.5588/ijtld.11.0821]
12. Samandari T, Agizew TB, Nyirenda S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: A randomised, double-blind, placebo-controlled trial. Lancet 2011;377(9777):1588-1598. [http://dx.doi.org/10.1016/S0140-6736(11)60204-3]
13. Martinson NA, Barnes GL, Moulton LH, et al. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med 2011;365(1):11-20. [http://dx.doi.org/10.1056/NEJMoa1005136]
14. Churchyard GJ, Fielding KL, Lewis JJ, Coetzee L, Godfrey-Faussett P, Hayes RJ. A trial of community-wide isoniazid preventive therapy for tuberculosis control. N Engl J Med 2014;370(4):301-310. [http://dx.doi.org/10.1056/NEJMoa1214289]
15. National Department of Health. The South African Antiretroviral Treatment Guidelines 2013. http://www.sanac.org.za/resources/cat_view/1-resources (accessed 14 October 2013).
16. O'Donnell MR, Jarand J, Loveday M, et al. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers. Ann Intern Med 2010;153(8):516-522. [http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00008]
17. Suthar AB, Lawn SD, del Amo J, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: A systematic review and meta-analysis. PLoS Med 2012;9(7):e1001270. [http://dx.doi.org/10.1371/journal.pmed.1001270]
18. Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: Comparison with rates in thecommunity. PLoS One 2012;7(3):e34156. [http://dx.doi.org/10.1371/journal.pone.0034156]
19. Rangaka MX, Boulle A, Wilkinson RJ, et al. Randomized controlled trial of isoniazid preventivetherapy in HIV-infected persons on antiretroviral therapy. Presented at the 19th International AIDS Conference, Washington, DC, USA, 22-27 July 2012. Abstract THLBB03.
20. Lawn SD, Harries AD, Williams BG et al. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis 2011;15(5):571-581. [http://dx.doi.org/10.5588/ijtld.10.0483]
21. National Department of Health. Multidrug resistant tuberculosis: A policy framework on decentralised and deinstitutionalised management for South Africa. http://www.doh.gov.za/docs/policy/2011/policy_TB.pdf (accessed 4 November 2013).
22. National Department of Health. Management of drug-resistant tuberculosis: Policy guidelines. http://www.tbonline.info/media/uploads/documents/mdr-tb_sa_2010.pdf (accessed 4 November 2013).
23. World Health Organization. Global Tuberculosis Report 2013. Geneva: WHO, 2012. http://www.who.int/tb/publications/global_report/en/index.html (accessed 21 January 2013).
24. World Health Organization. Rapid advice: Treatment of tuberculosis in children. http://whqlibdoc.who.int/publications/2010/9789241500449_eng.pdf (accessed 4 November 2013).
25. Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 2011;365(16):1492-1501. [http://dx.doi.org/10.1056/NEJMoa1014181]
26. Coetzee D, Hilderbrand K, Goemaere E, Matthys F, Boelaert M. Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health 2004;9(6):A11-A15. [http://dx.doi.org/10.1111/j.1365-3156.2004.01259.x]
27. Zwarenstein M, Fairall LR, Lombard C, et al. Outreach education for integration of HIV/AIDS care, antiretroviral treatment, and tuberculosis care in primary care clinics in South Africa: PALSA PLUS pragmatic cluster randomised trial. BMJ 2011;342:d2022. [http://dx.doi.org/10.1136/bmj.d2022]
28. National Department of Health. A practical guide for TB and HIV service integration at primaryhealth care facilities. http://www.sanacws.org.za/en/resource-centre/download/4ff15962e6d5d-guide-on-tb-and-hiv-integration-at-facility-level-pdf (accessed 4 November 2013).
29. Legido-Quigley H, Montgomery CM, Khan P, et al. Integrating tuberculosis and HIV services in lowand middle-income countries: A systematic review. Trop Med Int Health 2013;18(2):199-211. [http://dx.doi.org/10.1111/tmi.12029]
30. Mayosi BM, Lawn JE, van Niekerk A, Bradshaw D, Abdool Karim SS, Coovadia HM. Health inSouth Africa: Changes and challenges since 2009. Lancet 2012;380(9858):2029-2043. [http://dx.doi.org/10.1016/S0140-6736(12)61814-5]
31. Telisinghe L, Fielding K, Malden J, et al. Tuberculosis prevalence in a South African prison: Time to implement intensive TB screening. Int J Tuberc Lung Dis 2011;15(Suppl 3):S68.
32. Abu-Raddad LJ, Sabatelli L, Achterberg JT, et al. Epidemiological benefits of more-effectivetuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A 2009;106(33):13980-13985. [http://dx.doi.org/10.1073/pnas.0901720106]